Withholding and withdrawing treatment for cost-effectiveness reasons: Are they ethically on par?

In healthcare priority settings, early access to treatment before reimbursement decisions gives rise to problems of whether negative decisions for cost-effectiveness reasons should result in withdrawing treatment, already accessed by patients. Among professionals there seems to be a strong attitude...

Ausführliche Beschreibung

Gespeichert in:  
Bibliographische Detailangaben
VerfasserInnen: Sandman, Lars (Verfasst von) ; Liliemark, Jan (Verfasst von)
Medienart: Elektronisch Aufsatz
Sprache:Englisch
Verfügbarkeit prüfen: HBZ Gateway
Fernleihe:Fernleihe für die Fachinformationsdienste
Veröffentlicht: [2019]
In: Bioethics
Jahr: 2019, Band: 33, Heft: 2, Seiten: 278-286
IxTheo Notationen:NCH Medizinische Ethik
weitere Schlagwörter:B COST effectiveness
B withholding
B withdrawing
B equivalence thesis
B priority setting
Online-Zugang: Volltext (Verlag)
Volltext (doi)

MARC

LEADER 00000caa a22000002c 4500
001 1727521919
003 DE-627
005 20210927083513.0
007 cr uuu---uuuuu
008 200820s2019 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.12545  |2 doi 
035 |a (DE-627)1727521919 
035 |a (DE-599)KXP1727521919 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Sandman, Lars  |e VerfasserIn  |4 aut 
245 1 0 |a Withholding and withdrawing treatment for cost-effectiveness reasons  |b Are they ethically on par? 
264 1 |c [2019] 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a In healthcare priority settings, early access to treatment before reimbursement decisions gives rise to problems of whether negative decisions for cost-effectiveness reasons should result in withdrawing treatment, already accessed by patients. Among professionals there seems to be a strong attitude to distinguish between withdrawing and withholding treatment, viewing the former as ethically worse. In this article the distinction between withdrawing and withholding treatment for reasons of cost effectiveness is explored by analysing the doing/allowing distinction, different theories of justice, consequentialist and virtue perspectives. The authors do not find any strong reasons for an intrinsic difference, but do find some reasons for a consequentialist difference, given present attitudes. However, overall, such a difference does not, all things considered, provide a convincing reason against withdrawal, given the greater consequentialist gain of using cost-effective treatment. As a result, patients should be properly informed when given early access to treatment, that such treatment can be later withdrawn following a negative reimbursement decision. 
650 4 |a COST effectiveness 
650 4 |a equivalence thesis 
650 4 |a priority setting 
650 4 |a withdrawing 
650 4 |a withholding 
652 |a NCH 
700 1 |a Liliemark, Jan  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 33(2019), 2, Seite 278-286  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnas 
773 1 8 |g volume:33  |g year:2019  |g number:2  |g pages:278-286 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12545  |x Verlag 
856 |u https://doi.org/10.1111/bioe.12545  |x doi  |3 Volltext 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 3741319597 
LOK |0 003 DE-627 
LOK |0 004 1727521919 
LOK |0 005 20210927083513 
LOK |0 008 200820||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo 
LOK |0 936ln  |0 1550736558  |a NCH 
ORI |a SA-MARC-ixtheoa001.raw